Specify Company / Ticker to Get the Summary
Dividend History CNTB
Dividend Analytics CNTB
Max Ratio
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Connect Biopharma Holdings Ltd
CNTBConnect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States. The company's lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is in Phase 3 studies for the treatment of inflammatory diseases such as atopic dermatitis and asthma. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California. Address: 3580 CARMEL MOUNTAIN ROAD, San Diego, CA, United States, 92130
Analytics
WallStreet Target Price
6.50 USDP/E Ratio
–Dividend Yield
–Financials CNTB
Results | 2019 | Dynamics |